Movatterモバイル変換


[0]ホーム

URL:


JPS5095285A - - Google Patents

Info

Publication number
JPS5095285A
JPS5095285AJP14394773AJP14394773AJPS5095285AJP S5095285 AJPS5095285 AJP S5095285AJP 14394773 AJP14394773 AJP 14394773AJP 14394773 AJP14394773 AJP 14394773AJP S5095285 AJPS5095285 AJP S5095285A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14394773A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to JP14394773ApriorityCriticalpatent/JPS5095285A/ja
Publication of JPS5095285ApublicationCriticalpatent/JPS5095285A/ja
Pendinglegal-statusCriticalCurrent

Links

JP14394773A1973-12-261973-12-26PendingJPS5095285A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
JP14394773AJPS5095285A (en)1973-12-261973-12-26

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
JP14394773AJPS5095285A (en)1973-12-261973-12-26

Publications (1)

Publication NumberPublication Date
JPS5095285Atrue JPS5095285A (en)1975-07-29

Family

ID=15350740

Family Applications (1)

Application NumberTitlePriority DateFiling Date
JP14394773APendingJPS5095285A (en)1973-12-261973-12-26

Country Status (1)

CountryLink
JP (1)JPS5095285A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1995018097A1 (en)*1993-12-271995-07-06Eisai Co., Ltd.Anthranilic acid derivative
JP2006513154A (en)*2002-10-212006-04-20ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and / or cortical neuron activity modulators
US8278357B2 (en)2002-10-212012-10-02Ramot At Tel-Aviv University Ltd.Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
WO2012131656A3 (en)*2011-04-012012-11-22Société SplicosCompounds for use as therapeutic agents affecting p53 expression and/or activity
US8765815B2 (en)2007-09-202014-07-01Ramot At Tel-Aviv University Ltd.N-phenyl anthranilic acid derivatives and uses thereof
US9233931B2 (en)2008-01-102016-01-12Centre Nationale De Recherche ScientifiqueChemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
JP2016530317A (en)*2013-09-112016-09-29ジ・アドミニストレーターズ・オブ・ザ・チューレーン・エデュケーショナル・ファンド Novel anthranilamides and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS4840789A (en)*1971-10-071973-06-15

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS4840789A (en)*1971-10-071973-06-15

Cited By (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1995018097A1 (en)*1993-12-271995-07-06Eisai Co., Ltd.Anthranilic acid derivative
JP2006513154A (en)*2002-10-212006-04-20ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and / or cortical neuron activity modulators
US8278357B2 (en)2002-10-212012-10-02Ramot At Tel-Aviv University Ltd.Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
US8618169B2 (en)2002-10-212013-12-31Ramot At Tel-Aviv University Ltd.Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
US8765815B2 (en)2007-09-202014-07-01Ramot At Tel-Aviv University Ltd.N-phenyl anthranilic acid derivatives and uses thereof
US9403756B2 (en)2007-09-202016-08-02Ramot At Tel-Aviv University Ltd.N-phenyl anthranilic acid derivatives and uses thereof
US10130595B2 (en)2008-01-102018-11-20Centre Nationale De Recherche ScientifiqueChemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
US9233931B2 (en)2008-01-102016-01-12Centre Nationale De Recherche ScientifiqueChemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
US10654813B2 (en)2008-01-102020-05-19Centre National De La Recherche ScientifiqueChemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
WO2012131656A3 (en)*2011-04-012012-11-22Société SplicosCompounds for use as therapeutic agents affecting p53 expression and/or activity
US9890112B2 (en)2011-04-012018-02-13AbivaxCompounds for use as therapeutic agents affecting p53 expression and/or activity
US10538485B2 (en)2011-04-012020-01-21AbivaxCompounds for use as therapeutic agents affecting P53 expression and/or activity
JP2016530317A (en)*2013-09-112016-09-29ジ・アドミニストレーターズ・オブ・ザ・チューレーン・エデュケーショナル・ファンド Novel anthranilamides and their use
US11465978B2 (en)2013-09-112022-10-11The Administrators Of The Tulane Educational FundAnthranilic amides and the use thereof

Similar Documents

PublicationPublication DateTitle
AR201758A1 (en)
AU476761B2 (en)
AU465372B2 (en)
AR201235Q (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU465434B2 (en)
AU450229B2 (en)
AU476714B2 (en)
AR201229Q (en)
AU476696B2 (en)
AU466283B2 (en)
AU472848B2 (en)
AR199451A1 (en)
AU477823B2 (en)
AU471461B2 (en)
AR195948A1 (en)
AU447540B2 (en)
AU477824B2 (en)
AU461342B2 (en)
AR210729A1 (en)

[8]ページ先頭

©2009-2025 Movatter.jp